Phase I Trial of Ixabepilone and Vorinostat in Metastatic Breast Cancer.
Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 10 Apr 2018
At a glance
- Drugs Ixabepilone (Primary) ; Vorinostat (Primary)
- Indications Advanced breast cancer
- Focus Adverse reactions; Pharmacokinetics
- 04 Apr 2018 Planned End Date changed from 1 Mar 2018 to 1 Jun 2019.
- 04 Apr 2018 Planned primary completion date changed from 1 Jun 2018 to 1 Jun 2019.
- 04 Apr 2017 Planned primary completion date changed from 1 Mar 2018 to 1 Jun 2018.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History